PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $310,000 | -42.6% | 101,947 | +65.2% | 0.00% | -75.0% |
| Q4 2019 | $540,000 | +241.8% | 61,711 | +320.4% | 0.00% | +300.0% |
| Q3 2019 | $158,000 | -72.4% | 14,678 | -67.5% | 0.00% | -80.0% |
| Q2 2019 | $573,000 | +59.2% | 45,100 | +384.9% | 0.01% | +150.0% |
| Q1 2019 | $360,000 | +16.5% | 9,300 | -38.8% | 0.00% | 0.0% |
| Q4 2018 | $309,000 | -20.6% | 15,199 | +79.1% | 0.00% | +100.0% |
| Q3 2018 | $389,000 | +872.5% | 8,486 | +1314.3% | 0.00% | – |
| Q3 2016 | $40,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |